FREE MEMBERSHIP Includes » ABL Advisor eNews + iData Blasts | JOIN NOW ABLAdvisor Gray ABLAdvisor Blue
Skip Navigation LinksHome / News / Read News


Hercules Capital Provides Up to $65MM Senior Credit Facility to Sight Sciences

January 24, 2024, 08:00 AM
Filed Under: Medical

Sight Sciences, an eyecare technology company focused on developing and commercializing innovative technology intended to transform care and improve patients’ lives, closed an up to $65 million senior secured credit facility with Hercules Capital. The transaction included the immediate draw of $35 million, the net proceeds of which the Company used to pay off the principal amount of the Company’s indebtedness to its previous secured lender.

“This new facility further strengthens our balance sheet and enhances our ability to execute our strategic plan,” said Ali Bauerlein, Chief Financial Officer of Sight Sciences. “We are excited to partner with the Hercules team and are pleased to extend our cash runway and expand financial flexibility through the support and confidence of a leading growth medtech lender like Hercules. We feel Hercules is an ideal partner for us moving forward as we scale our business over the coming years.”

“This capital commitment from Hercules aims to help Sight Sciences deliver on its important mission to transform the treatment of eye diseases by treating the underlying causes,” said Lake McGuire, Managing Director at Hercules Capital. “We are proud to partner with the Sight Sciences team and provide them with improved financial flexibility.”

Key Credit Facility Terms:

  • $35 million funded at loan closing, with up to an additional $30 million potentially available (subject to certain conditions as described in the credit agreements)
  • 54-month maturity, with interest-only period of 30 months, which can be extended to 36 months subject to achievement of certain performance milestones

The credit facility is secured by substantially all of the Company’s assets.

Week's News

Comments From Our Members

You must be an ABL Advisor member to post comments. Login or Join Now.